New program aims to boost muscle in cystic fibrosis patients on trikafta
NCT ID NCT06457451
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a one-year program of remote exercise sessions and personalized diet advice can increase lean muscle mass in 100 adults with cystic fibrosis who are already taking the drug Trikafta. The program is designed to address new nutritional challenges, like weight gain and metabolic issues, that can arise with Trikafta. Researchers will measure changes in muscle mass, strength, and endurance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DIAPASOM program (dietary counseling and adapted physical activity)
What this could lead to
If successful, this program could help people with cystic fibrosis build and maintain muscle mass, improving their strength and overall health.
What could go wrong
This is a small, early-stage trial focused on a supportive therapy, not a cure. The program may not lead to significant muscle gain, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cystic Fibrosis Resource and Competence Centre, Fondation Ildys, Roscoff
RECRUITINGRoscoff, 29684, France
Contact
Contact
-
Cystic Fibrosis Resource and Competence Centre, Hospital, Tours
RECRUITINGVannes, 56017, France
Contact
Contact
-
Cystic Fibrosis Resource and Competence Centre, University Hospital, Angers
RECRUITINGAngers, 49033, France
Contact
Contact
-
Cystic Fibrosis Resource and Competence Centre, University Hospital, Tours
RECRUITINGTours, 37044, France
Contact
Contact